Related references
Note: Only part of the references are listed.Mutual Expression of ALDH1A1, LOX, and Collagens in Ovarian Cancer Cell Lines as Combined CSCs- and ECM-Related Models of Drug Resistance Development
Karolina Sterzynska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
New and Old Genes Associated with Primary and Established Responses to Paclitaxel Treatment in Ovarian Cancer Cell Lines
Monika Swierczewska et al.
MOLECULES (2018)
The Role of Matrix Gla Protein (MGP) Expression in Paclitaxel and Topotecan Resistant Ovarian Cancer Cell Lines
Karolina Sterzynska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Mechanisms of Drug Resistance in High-Grade Serous Ovarian Cancer
Alison E. Freimund et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2018)
Myotilin, a New Topotecan Resistant Protein in Ovarian Cancer Cell Lines
Karolina Sterzynska et al.
JOURNAL OF CANCER (2018)
The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy
Fatima Ardito et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer
Dimakatso Alice Senthebane et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Differential Functional Roles of ALDH1A1 and ALDH1A3 in Mediating Metastatic Behavior and Therapy Resistance of Human Breast Cancer Cells
Alysha K. Croker et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Ovarian cancer stem cells: still an elusive entity?
Michela Lupia et al.
MOLECULAR CANCER (2017)
New and Old Genes Associated with Primary and Established Responses to Cisplatin and Topotecan Treatment in Ovarian Cancer Cell Lines
Monika Swierczewska et al.
MOLECULES (2017)
The significance of lumican expression in ovarian cancer drug-resistant cell lines
Andrzej Klejewski et al.
ONCOTARGET (2017)
Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell lines
Radoslaw Januchowski et al.
ONCOTARGET (2017)
Therapeutic Targeting of Oncogenic Tyrosine Phosphatases
Rochelle Frankson et al.
CANCER RESEARCH (2017)
Epidemiology of epithelial ovarian cancer
Penelope M. Webb et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2017)
New and Old Genes Associated with Topotecan Resistance Development in Ovarian Cancer Cell Lines
Andrzej Klejewski et al.
ANTICANCER RESEARCH (2017)
Cell signaling regulation by protein phosphorylation: a multivariate, heterogeneous, and context-dependent process
Evan K. Day et al.
CURRENT OPINION IN BIOTECHNOLOGY (2016)
Inhibition of ALDH1A1 activity decreases expression of drug transporters and reduces chemotherapy resistance in ovarian cancer cell lines
Radoslaw Januchowski et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines
Radoslaw Januchowski et al.
JOURNAL OF OVARIAN RESEARCH (2016)
Aldehyde dehydrogenase 1A1 in stem cells and cancer
Hiroyuki Tomita et al.
ONCOTARGET (2016)
Increased Expression of Several Collagen Genes is Associated with Drug Resistance in Ovarian Cancer Cell Lines
Radoslaw Januchowski et al.
JOURNAL OF CANCER (2016)
Ovarian cancer
Ursula A. Matulonis et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Inhibition of protein glycosylation reverses the MDR phenotype of cancer cell lines
Karolina Wojtowicz et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
Receptor-type tyrosine-protein phosphatase κ directly targets STAT3 activation for tumor suppression in nasal NK/T-cell lymphoma
Yun-Wen Chen et al.
BLOOD (2015)
Regulation of development and cancer by the R2B subfamily of RPTPs and the implications of proteolysis
Sonya E. L. Craig et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2015)
Receptor-type protein tyrosine phosphatases in cancer
Yu Du et al.
CHINESE JOURNAL OF CANCER (2015)
Expression of MDR1 and MDR3 gene products in paclitaxel-, doxorubicin- and vincristine-resistant cell lines
Radoslaw Januchowski et al.
BIOMEDICINE & PHARMACOTHERAPY (2014)
DNA methylation of membrane-bound tyrosine phosphatase genes in acute lymphoblastic leukaemia
W. S. Stevenson et al.
LEUKEMIA (2014)
Microarray-based detection and expression analysis of extracellular matrix proteins in drug-resistant ovarian cancer cell lines
Radoslaw Januchowski et al.
ONCOLOGY REPORTS (2014)
Extracellular Matrix Proteins Expression Profiling in Chemoresistant Variants of the A2780 Ovarian Cancer Cell Line
Radoslaw Januchowski et al.
BIOMED RESEARCH INTERNATIONAL (2014)
The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance
Radoslaw Januchowski et al.
BIOMEDICINE & PHARMACOTHERAPY (2013)
Protein tyrosine phosphatase kappa (PTPRK) is a negative regulator of adhesion and invasion of breast cancer cells, and associates with poor prognosis of breast cancer
Ping-Hui Sun et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Tumor Derived Mutations of Protein Tyrosine Phosphatase Receptor Type K Affect Its Function and Alter Sensitivity to Chemotherapeutics in Glioma
Supreet Agarwal et al.
PLOS ONE (2013)
MDR Gene Expression Analysis of Six Drug-Resistant Ovarian Cancer Cell Lines
Radoslaw Januchowski et al.
BIOMED RESEARCH INTERNATIONAL (2013)
The tumor microenvironment is a dominant force in multidrug resistance
Ana Luisa Correia et al.
DRUG RESISTANCE UPDATES (2012)
BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation-Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
Kathryn Alsop et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Enhancing Diagnosis, Prognosis, and Therapeutic Outcome Prediction of Gliomas Using Genomics
Mahfoud Assem et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
Regulation of ABC Transporter Function Via Phosphorylation by Protein Kinases
Elzbieta I. Stolarczyk et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Beyond chemotherapy: targeted therapies in ovarian cancer
Timothy A. Yap et al.
NATURE REVIEWS CANCER (2009)
p21 and p27: roles in carcinogenesis and drug resistance
Abde M. Abukhdeir et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2008)
The 44-kDa pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells
Yingqiu Xie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
James A. McCubrey et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
The crystal structure of human receptor protein tyrosine phosphatase κ phosphatase domain 1
Jeyanthy Eswaran et al.
PROTEIN SCIENCE (2006)
Protein-tyrosine phosphatases and cancer
A Östman et al.
NATURE REVIEWS CANCER (2006)
Protein tyrosine phosphatase genes downregulated in melanoma
L McArdle et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
Share Paper
